Xoma Corporation (XOMAO)

概要ニュース株価時系列 Financials ディスカッション予測株の配当実績

Relative Volume:

ネットキャッシュフロー:

Xoma Corporation Stock (XOMAO) Company Profile

Xoma Corporation

Healthcare (1134)

Biotechnology (634)

510 204 7200

2200 Powell Street, Suite 310, EmeryVille

XOMAO's Discussions on Twitter

XOMAO を他の銘柄と比較する

株式	価格	時価総額	収益	当期純利益	現金流量	EPS
XOMAO Xoma Corporation	25.45	0	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	447.38	114.05B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	748.71	78.80B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	396.04	51.80B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	847.05	53.08B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	166.55	42.33B	447.02M	-1.18B	-906.14M	-6.1812

Xoma Corporation (XOMAO) 最新ニュース

Xoma Corporation (XOMAO) 財務データ

Xoma Corporation (XOMAO) の財務データはありません。詳細については、他の銘柄を確認してください。

Xoma Corporation (XOMAO)

Xoma Corporation Stock (XOMAO) Company Profile

XOMAO を他の銘柄と比較する

Xoma Corporation (XOMAO) 最新ニュース

Can XOMA Royalty Corporation stock double in next 5 yearsWeekly Trade Review & Free Risk Controlled Daily Trade Plans - Улправда

Will XOMA Royalty Corporation (X0M1) stock profit from fiscal stimulusM&A Rumor & Risk Adjusted Buy and Sell Alerts - Улправда

Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced By Investing.com - Investing.com South Africa

Generation Bio is latest Mass. biotech to be acquired by Xoma - The Business Journals

XOMA to buy struggling Generation Bio - The Pharma Letter

Jefferies downgrades Generation Bio stock to Hold as XOMA acquisition announced - Investing.com Nigeria

‘Zombie’ biotech buyer Xoma to acquire Generation Bio - Yahoo Finance

XOMA Strikes Deal To Acquire Generation Bio, Expanding Royalty Portfolio - Nasdaq

XOMA Royalty to Acquire Generation Bio - citybiz

Generation Bio Announces Merger with XOMA Royalty - TipRanks

Xoma Royalty enters into agreement to acquire Generation Bio - marketscreener.com

XOMA Royalty Corporation to Acquire Generation Bio Co. in Cash Transaction with Milestone and Royalty Opportunities - Quiver Quantitative

Generation Bio (NASDAQ: GBIO) agrees to $4.29 sale to XOMA Royalty plus CVR - Stock Titan

Investors Don't See Light At End Of XOMA Royalty Corporation's (NASDAQ:XOMA) Tunnel - simplywall.st

Generation Bio (GBIO) to be acquired in planned XOMA tender offer - Stock Titan

FY2025 EPS Estimates for XOMA Royalty Reduced by Analyst - MarketBeat

XOMA Royalty Corporation: A Deep Dive into a Biotech Royalty Aggregator (12/13/2025) - Markets Financial Content

BVF Inc. IL Has $65.28 Million Stock Position in XOMA Royalty Corporation $XOMA - MarketBeat

Why (XOMAO) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com

Price-Driven Insight from (XOMA) for Rule-Based Strategy - news.stocktradersdaily.com

XOMA stock maintains Buy rating at Benchmark despite partner’s trial setback - Investing.com

XOMA: HC Wainwright Maintains Buy Rating, Lowers Price Target to $97 | XOMA Stock News - GuruFocus

Leerink Partners lowers XOMA stock price target on RZ358 trial failure By Investing.com - Investing.com South Africa

HC Wainwright & Co. Maintains XOMA Royalty (XOMA) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains XOMA Royalty CorporationPreferred Stock (XOMAP) Buy Recommendation - Nasdaq

Why two Bay Area companies' stocks tumbled on a drug's clinical failure - The Business Journals

XOMA stock price target lowered to $97 by H.C. Wainwright - Investing.com Australia

XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Rating of "Hold" from Brokerages - MarketBeat

XOMA: Leerink Partners Lowers Price Target, Reiterates Outperfor - GuruFocus

Why Is XOMA Royalty Stock Sinking Thursday? - Benzinga

Leerink Partners lowers XOMA stock price target on RZ358 trial failure - Investing.com

LUCID CAPITAL MARKETS Initiates Coverage of XOMA Royalty CorporationPreferred Stock (XOMAP) with Buy Recommendation - Nasdaq

LUCID CAPITAL MARKETS Initiates Coverage of XOMA Royalty (XOMA) with Buy Recommendation - Nasdaq

Lucid Capital Markets initiates coverage on XOMA stock with Buy rating - Investing.com Canada

XOMA Royalty (XOMA): New Buy Rating Initiated by Lucid Capital M - GuruFocus

Xoma initiated with a Buy at Lucid Capital - TipRanks

CEO’s Bold Move: Massive Investment in Xoma Stock! - TipRanks

Insider Buying: XOMA Royalty (NASDAQ:XOMA) CEO Acquires 100,000 Shares of Stock - MarketBeat

XOMA Royalty Corp CEO Owen Hughes Acquires 100,000 Depositary Shares - TradingView

Xoma Royalty Expands Portfolio Through Mural Oncology Acquisition - AD HOC NEWS

XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share - Investing.com Nigeria

XOMA Royalty completes acquisition of Mural Oncology By Investing.com - Investing.com Nigeria

Xoma Completes Acquisition of Mural Oncology - TipRanks

Xoma announces closing of transaction to acquire Mural Oncology - TipRanks

XOMA Royalty completes acquisition of Mural Oncology for $2.035 per share By Investing.com - Investing.com South Africa

Mural Oncology Announces Effectiveness of Scheme of Arrangement and Completion of Acquisition - Research Tree

Xoma Royalty announces closing of transaction to acquire Mural Oncology plc - marketscreener.com

XOMA Royalty Corporation Completes Acquisition of Mural Oncology plc Under Irish High Court Sanctioned Scheme - Quiver Quantitative

XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - The Manila Times

XOMA Royalty (Nasdaq: XOMA) completes $2.035 per share Mural Oncology takeover - Stock Titan

XOMA Royalty completes acquisition of Mural Oncology - Investing.com India

Xoma Corporation (XOMAO) 財務データ

収益

当期純利益

現金流量

EPS

XOMAOに似た銘柄